Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive Pulmonary Disease (COPD)

Overview of attention for article published in Respiratory Research, October 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 34 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 4,391 followers.

RT @RespiratoryBMC: New article: Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive…

19 Nov 2019

Reply Repost Favourite

#respiratoryresearch Maintained therapeutic effect of revefenacin over 52 weeks in moderate… https://t.co/pEfEkepzrP

02 Nov 2019

Reply Repost Favourite

New article: Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive Pulmonary Disease (COPD) https://t.co/TmfyqDbjWe

31 Oct 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.